NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH-NCI
Grant: CA148671
NIH-NCI
Grant: P20RR016440
NIH-NCI
Grant: P30GM103488
NIH-NCI
Grant: U54GM104942
NIH-NCI
Grant: P20GM103434
NIH-NCI
Grant: S10RR026378
NCI NIH HHS
Grant: R01 CA148671
FWCI
1.58
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer
Additional file 1 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer
Additional file 3 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer
Additional file 3 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer
Additional file 2 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer
Additional file 2 of Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer